Investigators at the Ragon Institute of MGH, MIT and Harvard have used a novel approach to identify specific amino acids in the protein structure of HIV that appear critical to the ability of the ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Codiak BioSciences, Inc., a company at the forefront of advancing engineered exosomes as a new class of biologic medicines, today announced that it has entered into ...
ReiThera Srl, the Ragon Institute of Mass General, MIT, and Harvard, and IAVI are pleased to announce a collaboration to develop a novel HIV vaccine candidate that will be composed of ReiThera’s GRAd ...
Investigators from Massachusetts General Hospital (MGH) and the Ragon Institute of MGH, MIT and Harvard have learned more about one way the immune systems of elite controllers – those rare individuals ...
It’s opening day at the Ragon Institute’s new building, a sparkling 30,000-square-meter glass-and-steel edifice on Main Street in Cambridge, Massachusetts. Governor Maura Healey, New England Patriots ...
A leading AIDS research center unveiled its new $30 million laboratory building in Cambridge Monday, where it aims to push ahead with efforts to develop an HIV vaccine and to study tuberculosis, which ...
A program established by investigators from the Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard is addressing the persistently elevated risk of HIV infection among young women ...
Microsoft Research is collaborating with the Ragon Institute, using its expertise in fighting spam to seek weaknesses in HIV. Microsoft Research is collaborating with the Ragon Institute, using its ...
On a May afternoon in 2008, Bruce Walker and Terry Ragon ’71 paid a recruiting visit to MIT. Walker is a Harvard Medical School physician who has studied HIV for three decades; Ragon, the founder and ...
It’s opening day at the Ragon Institute’s new building, a sparkling 323,000-square-foot glass-and-steel edifice on Main Street in Cambridge, Massachusetts. Governor Maura Healey, New England Patriots ...
A phase 2b clinical trial of a novel preventive HIV vaccine regimen developed by researchers at the Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard, Beth Israel Deaconess ...
ReiThera Srl, the Ragon Institute of Mass General, MIT, and Harvard, and IAVI are pleased to announce a collaboration to develop a novel HIV vaccine candidate that will be composed of ReiThera’s GRAd ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results